JNJ
224.16
-1.45%↓
UNH
370.76
+0.47%↑
TMO
462.35
-1.48%↓
ISRG
452.39
-1.14%↓
ABT
87.56
-2.18%↓
JNJ
224.16
-1.45%↓
UNH
370.76
+0.47%↑
TMO
462.35
-1.48%↓
ISRG
452.39
-1.14%↓
ABT
87.56
-2.18%↓
JNJ
224.16
-1.45%↓
UNH
370.76
+0.47%↑
TMO
462.35
-1.48%↓
ISRG
452.39
-1.14%↓
ABT
87.56
-2.18%↓
JNJ
224.16
-1.45%↓
UNH
370.76
+0.47%↑
TMO
462.35
-1.48%↓
ISRG
452.39
-1.14%↓
ABT
87.56
-2.18%↓
JNJ
224.16
-1.45%↓
UNH
370.76
+0.47%↑
TMO
462.35
-1.48%↓
ISRG
452.39
-1.14%↓
ABT
87.56
-2.18%↓
24h
Atual
Mín
8.63
Máximo
8.79
Rendimento | -69M -102M |
|---|---|
Vendas | -10M 34M |
EPS | -5.69 |
Margem de lucro | -299.886 |
Funcionários | 228 |
EBITDA | 4.7M -18M |
Recomendações | Compra Forte |
|---|---|
Previsão para 12 meses | +89.28% upside |
Capitalização de Mercado | 38M 195M |
|---|---|
Abertura anterior | 3.04 |
Fecho anterior | 8.73 |
By Acuity
43%
57%
155 / 347 Ranking em Healthcare
By Trading Central
Confiança
Bullish Evidence
5.9501 / 7.66 Suporte e Resistência
O desempenho passado não é um indicador confiável de resultados futuros.
4 de mai. de 2026, 22:17 UTC
Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%
DJ
Ler
4 de mai. de 2026, 23:47 UTC
Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB
DJ
Ler
4 de mai. de 2026, 23:45 UTC
Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB
DJ
Ler
4 de mai. de 2026, 23:45 UTC
Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB
DJ
Ler
4 de mai. de 2026, 23:40 UTC
Gold Steady Amid Likely Technical Recovery -- Market Talk
DJ
Ler
4 de mai. de 2026, 22:44 UTC
Regis: Jim Beyer To Be Chief Executive of Combined Company
DJ
Ler
4 de mai. de 2026, 22:43 UTC
Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company
DJ
Ler
4 de mai. de 2026, 22:42 UTC
Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits
DJ
Ler
4 de mai. de 2026, 22:42 UTC
Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation
DJ
Ler
4 de mai. de 2026, 22:41 UTC
Regis: Combined Company to Have Annual Production of More Than 700,000 Oz
DJ
Ler
4 de mai. de 2026, 22:41 UTC
Regis: Pro Forma Market Capitalization About A$10.7 Billion
DJ
Ler
4 de mai. de 2026, 22:40 UTC
Regis: Shareholders to Own About 51% of Combined Company
DJ
Ler
4 de mai. de 2026, 22:40 UTC
Regis: Board Unanimously Endorsed, Supported Deal
DJ
Ler
4 de mai. de 2026, 22:40 UTC
Regis: Deal Unanimously Recommended by Vault Board
DJ
Ler
4 de mai. de 2026, 22:39 UTC
Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held
DJ
Ler
4 de mai. de 2026, 22:38 UTC
Regis Resources to Acquire All Ordinary Shares in Vault
DJ
Ler
4 de mai. de 2026, 22:38 UTC
Regis Resources, Vault Minerals Agree to Merger of Equals
DJ
Ler
4 de mai. de 2026, 22:37 UTC
Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update
DJ
Ler
4 de mai. de 2026, 22:26 UTC
Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update
DJ
Ler
4 de mai. de 2026, 22:02 UTC
Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%
DJ
Ler
4 de mai. de 2026, 22:00 UTC
BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk
DJ
Ler
4 de mai. de 2026, 21:52 UTC
Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:50 UTC
Westpac: Some Sectors More Affected Than Others>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:50 UTC
Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:49 UTC
Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:44 UTC
Westpac 1H Australia Lending Up 8% on Year>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:44 UTC
Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:43 UTC
Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:41 UTC
Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU
DJ
Ler
4 de mai. de 2026, 21:40 UTC
Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU
DJ
Ler
Variação de preço
By TipRanks
Previsão para 12 meses
Média 16.6 USD 89.28%
Máximo 28 USD
Mínimo 8 USD
Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Karyopharm Therapeutics Inc - Dist nos últimos 3 meses.
By TipRanks
Compra Forte
6 ratings
6
Comprar
0
Manter
0
Vender
Com base em 6 analistas que deram avaliações de ações para Karyopharm Therapeutics Inc - Dist nos últimos 3 meses.
By Trading Central
Curto Prazo
Bullish Evidence
Recent bullish events outweigh bearish events.
Médio Prazo
Strong Bearish Evidence
All events are bearish.
Longo Prazo
No Evidence
There are no events.
By Acuity
Sentimento de Notícias
Evidência de Tendência de Alta
Volatilidade
Abaixo da média
Volume de Notícias (RCV)
Acima da média
Custos administrativos e de venda
Custos Operacionais
Lucro antes de imposto
Vendas
Custo das vendas
Lucro bruto sobre vendas
Despesa com juros da dívida
EBITDA
Resultado Operacional
$